hydralazine has been researched along with Ventricular Dysfunction in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mozolevska, V | 1 |
| Schwartz, A | 1 |
| Cheung, D | 1 |
| Goyal, V | 1 |
| Shaikh, B | 1 |
| Dingman, B | 1 |
| Kim, E | 1 |
| Mittal, I | 1 |
| Asselin, CY | 1 |
| Edel, A | 1 |
| Ravandi, A | 1 |
| Thliveris, J | 1 |
| Singal, PK | 1 |
| Czaykowski, P | 1 |
| Jassal, DS | 1 |
1 other study available for hydralazine and Ventricular Dysfunction
| Article | Year |
|---|---|
Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antineoplastic Ag | 2019 |